Preview

Medical Herald of the South of Russia

Advanced search

EFFECTIVE AND SAFE MONOTHERAPY WITH INTRAVAGINAL NEO-PENOTRAN FORTE AND VAGINORM C SUPPOSITORIES

https://doi.org/10.21886/2219-8075-2014-2-30-33

Abstract

Purpose: Compare efficacy and safety of Neo-Penotran Forte and Vaginorm C intravaginal pharmaceuticals in bacterial vaginosis treatment.
Materials and methods: 84 female patients were inspected at the age from 18 to 45 years old, 31,5 years old in average, with bacterial vaginosis diagnosis. 42 patients were treated with Neo-Penotran Forte, and 42 patients were treated with Vaginorm C. All the female patients were divided in two groups in accordance with the used treatment mode: the 1st group was treated with Neo-penotran forte (vaginal suppositories) (n=42), the 2nd group was treated with Vaginorm C (vaginal tablets) (n=42). Treatment efficacy and safety was evaluated 3 days after the treatment was over and a month after the treatment was over.
Results: The treatment with Neo-Penotran Forte showed more pronounced clinical and laboratory effect both at the first and the second visits in comparison with Vaginorm C.
Summary: The most effective scheme of bacterial vaginosis treatment is metronidazole and miconazole combination. Efficacy of metronidazole and miconazole combination treatment is 100%, efficacy of ascorbic acid treatment is 80%.

About the Authors

N. S. Badikova
Clinical hospital of Administrative Department of the President of the Russian Federation
Russian Federation


E. F. Kira
Extension Course Institute for Medical Practitioners “N.I.Pirogov National medico-surgical center”
Russian Federation
department of gynecological diseases and reproductive health


References

1. Глобальная стратегия профилактики инфекций, передаваемых половым путем, и борьбы с ними, 2006-2015 гг.//Вестник дерматологии и венерологии. 2008. №4. С. 17-30.

2. Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis//Am J Obstet Gynecol 1995; 172: -С. 525-9.

3. Чайка В.К. Инфекции в акушерстве и гинекологии. Донецк, 2006. С. 512, 515.

4. Коршунов В.М., Володин Н.Н., Ефимов Б.А. и др. Микроэкология влагалища. Коррекция микрофлоры при вагинальных дисбактериозах//Учебное пособие. -М.: ВУНМЦ МЗ РФ. 1999. С. 80.

5. Минушкин О.Н., Ардатская М.Д., Дубинин А.В. Дисбактериоз кишечника: современные аспекты изучения проблемы, принципы диагностики и лечения//Терапевтический архив. 2001. № 2. С. 67-72.

6. Кира Е.Ф. Бактериальный вагиноз. -СПб: ООО «Нева_ Люкс», 2001. -С. 364.

7. Тютюнник В.Л. Фарматека. -М, 2005; 2: -С. 20-24.

8. Colli E., Landoni M., Parazzini F. Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial.//Genitourin Med. -1997. -Vol. 73. -N. 4. -P. 267-270.

9. Shaaban O.M., Fetih G.N., Abdellah N.H., Ismail S., Ibrahim M.A., Ibrahim E.S. Pilot randomized trial for treatment of bacterial vaginosis using in situ forming metronidazole vaginal gel//J. Obstet. Gynaecol. Res. -2011. -Vol. 37. -P. 874-881.

10. Анастасьева В.Г. Современные методы диагностики лечения и профилактики бактериального вагиноза. -Новосибирск: НМН, 2007. -С. 17


Review

For citations:


Badikova N.S., Kira E.F. EFFECTIVE AND SAFE MONOTHERAPY WITH INTRAVAGINAL NEO-PENOTRAN FORTE AND VAGINORM C SUPPOSITORIES. Medical Herald of the South of Russia. 2014;(2):30-33. (In Russ.) https://doi.org/10.21886/2219-8075-2014-2-30-33

Views: 1337


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2219-8075 (Print)
ISSN 2618-7876 (Online)